Lilly takes AI-selected Olumiant into phase 3 for COVID-19

Eli Lilly has enrolled the first patient into a phase 3 trial that is seeking to repurpose arthritis drug Olumiant as a treatment for people with COVID-19.

'Major breakthrough' as cheap steroid cuts deaths in COVID-1...

The answer to improving survival rates in people with severe respiratory complications caused by COVID-19 is a generic steroid drug that can be bought for a few pounds.

Big UK trial says hydroxychloroquine has no effect on COVID-...

The largest trial to date on hydroxychloroquine has concluded it has “no beneficial effect” when used to treat patients hospitalised with COVID-19.

hVIVO offers coronavirus antibody testing to UK employers

UK firm hVIVO has launched a coronavirus antibody testing service for big businesses that it says could help get employees back to work as lockdown eases.

FDA clears emergency use of Roche test for COVID-19 'cytokin...

Patient voice must be stronger in digital health, says advoc...

An advocacy group has issued a “call to action” to make sure patients are closely consulted in the development of digital health technologies.